Frederic R. Santer

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicity.

Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicity.

Journal: American journal of human genetics

Published: December 23, 2025

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Journal: Clinical and translational medicine

Published: October 31, 2025

Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cells.

Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cells.

Journal: Scientific reports

Published: October 22, 2025

The Global State of Contemporary Andrology Practice: A Comprehensive Analysis of Clinical Practice, Training Pathways, and Emerging Challenges.

The Global State of Contemporary Andrology Practice: A Comprehensive Analysis of Clinical Practice, Training Pathways, and Emerging Challenges.

Journal: The world journal of men's health

Published: January 30, 2025

Repurposing Amiodarone for Bladder Cancer Treatment.

Repurposing Amiodarone for Bladder Cancer Treatment.

Journal: Cancer research communications

Published: August 21, 2024

Biological and therapeutic implications of sex hormone-related gene clustering in testicular cancer.

Biological and therapeutic implications of sex hormone-related gene clustering in testicular cancer.

Journal: Basic and clinical andrology

Published: August 06, 2024

Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.

Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.

Journal: Therapeutic advances in urology

Published: May 28, 2024

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.

Journal: Molecular oncology

Published: March 13, 2024

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

Journal: The Journal of clinical investigation

Published: January 30, 2024

Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer.

Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer.

Journal: Nutrients

Published: April 13, 2023

Controversy and Consensus on the Management of Elevated Sperm DNA Fragmentation in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations.

Controversy and Consensus on the Management of Elevated Sperm DNA Fragmentation in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations.

Journal: The world journal of men's health

Published: January 12, 2023

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.

Journal: The American journal of pathology

Published: January 12, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026